Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1359 ARTÍCULOS , VIENDO DEL 1261 AL 1275

Mitophagy in neurodegeneration: an opportunity for therapy?

Santos RX, Correia SC, Carvalho C, Cardoso S, Santos MS, Moreira PI.

Curr Drug Targets. 2011 Jun;12(6):790-9. doi: 10.2174/138945011795528813.

Developing predictive CSF biomarkers-a challenge critical to success in Alzheimer's disease and neuropsychiatric translational medicine

Flood DG, Marek GJ, Williams M.

Biochem Pharmacol. 2011 Jun 15;81(12):1422-34. doi: 10.1016/j.bcp.2011.01.021. Epub 2011 Feb 3.

TDP-43 in aging and Alzheimer's disease - a review

Wilson AC, Dugger BN, Dickson DW, Wang DS.

Int J Clin Exp Pathol. 2011 Jan 30;4(2):147-55.

Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort

Boeve BF, Molano JR, Ferman TJ, Smith GE, Lin SC, Bieniek K, Haidar W, Tippmann-Peikert M, Knopman DS, Graff-Radford NR, Lucas JA, Petersen RC, Silber MH.

Sleep Med. 2011 May;12(5):445-53. doi: 10.1016/j.sleep.2010.12.009. Epub 2011 Feb 23.

Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim

Weinreb O, Mandel S, Bar-Am O, Amit T.

J Neural Transm (Vienna). 2011 Mar;118(3):479-92. doi: 10.1007/s00702-011-0597-6. Epub 2011 Mar 1.

Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases

Kawamata J, Shimohama S.

J Alzheimers Dis. 2011;24 Suppl 2:95-109. doi: 10.3233/JAD-2011-110173.

Metal ions, Alzheimer's disease and chelation therapy

Budimir A.

Acta Pharm. 2011 Mar;61(1):1-14. doi: 10.2478/v10007-011-0006-6.

Knowing me, knowing you: can a knowledge of risk factors for Alzheimer's disease prove useful in understanding the pathogenesis of Parkinson's disease?

Sutherland GT, Siebert GA, Kril JJ, Mellick GD.

J Alzheimers Dis. 2011;25(3):395-415. doi: 10.3233/JAD-2011-110026.

Correlates of care relationship mutuality among carers of people with Alzheimer's and Parkinson's disease

Shim B, Landerman LR, Davis LL.

J Adv Nurs. 2011 Aug;67(8):1729-38. doi: 10.1111/j.1365-2648.2011.05618.x. Epub 2011 Apr 4.

Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis

Luchetti S, Huitinga I, Swaab DF.

Neuroscience. 2011 Sep 15;191:6-21. doi: 10.1016/j.neuroscience.2011.04.010. Epub 2011 Apr 15.

DNA methylation in neurodegenerative disorders: a missing link between genome and environment?

Iraola-Guzmán S, Estivill X, Rabionet R.

Clin Genet. 2011 Jul;80(1):1-14. doi: 10.1111/j.1399-0004.2011.01673.x. Epub 2011 May 4.

FTLD-TDP with motor neuron disease, visuospatial impairment and a progressive supranuclear palsy-like syndrome: broadening the clinical phenotype of TDP-43 proteinopathies. A report of three cases

Rusina R, Kovacs GG, Fiala J, Hort J, Ridzoň P, Holmerová I, Ströbel T, Matěj R.

BMC Neurol. 2011 May 10;11:50. doi: 10.1186/1471-2377-11-50.

Alzheimer's disease

Selkoe DJ.

Cold Spring Harb Perspect Biol. 2011 Jul 1;3(7):a004457. doi: 10.1101/cshperspect.a004457.

Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases

Nakamura T, Lipton SA.

Cell Death Differ. 2011 Sep;18(9):1478-86. doi: 10.1038/cdd.2011.65. Epub 2011 May 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias